These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 18974298)
1. Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression. Roodink I; Kats G; van Kempen L; Grunberg M; Maass C; Verrijp K; Raats J; Leenders W Am J Pathol; 2008 Dec; 173(6):1873-81. PubMed ID: 18974298 [TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of semaphorin 3E is involved in the gastric cancer development. Maejima R; Tamai K; Shiroki T; Yokoyama M; Shibuya R; Nakamura M; Yamaguchi K; Abue M; Oikawa T; Noguchi T; Miura K; Fujiya T; Sato I; Iijima K; Shimosegawa T; Tanaka N; Satoh K Int J Oncol; 2016 Sep; 49(3):887-94. PubMed ID: 27572291 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis. Moriya J; Minamino T; Tateno K; Okada S; Uemura A; Shimizu I; Yokoyama M; Nojima A; Okada M; Koga H; Komuro I Circ Res; 2010 Feb; 106(2):391-8. PubMed ID: 19940264 [TBL] [Abstract][Full Text] [Related]
4. Vascular Sema3E-Plexin-D1 Signaling Reactivation Promotes Post-stroke Recovery through VEGF Downregulation in Mice. Yu R; Kim NS; Li Y; Jeong JY; Park SJ; Zhou B; Oh WJ Transl Stroke Res; 2022 Feb; 13(1):142-159. PubMed ID: 33978913 [TBL] [Abstract][Full Text] [Related]
5. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis. Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963 [TBL] [Abstract][Full Text] [Related]
6. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways. Aghajanian H; Choi C; Ho VC; Gupta M; Singh MK; Epstein JA J Biol Chem; 2014 Jun; 289(26):17971-9. PubMed ID: 24825896 [TBL] [Abstract][Full Text] [Related]
7. Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism. Kim J; Oh WJ; Gaiano N; Yoshida Y; Gu C Genes Dev; 2011 Jul; 25(13):1399-411. PubMed ID: 21724832 [TBL] [Abstract][Full Text] [Related]
8. Binding and complementary expression patterns of semaphorin 3E and plexin D1 in the mature neocortices of mice and monkeys. Watakabe A; Ohsawa S; Hashikawa T; Yamamori T J Comp Neurol; 2006 Nov; 499(2):258-73. PubMed ID: 16977617 [TBL] [Abstract][Full Text] [Related]
9. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545 [TBL] [Abstract][Full Text] [Related]
10. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. Casazza A; Finisguerra V; Capparuccia L; Camperi A; Swiercz JM; Rizzolio S; Rolny C; Christensen C; Bertotti A; Sarotto I; Risio M; Trusolino L; Weitz J; Schneider M; Mazzone M; Comoglio PM; Tamagnone L J Clin Invest; 2010 Aug; 120(8):2684-98. PubMed ID: 20664171 [TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein. Sakurai A; Jian X; Lee CJ; Manavski Y; Chavakis E; Donaldson J; Randazzo PA; Gutkind JS J Biol Chem; 2011 Sep; 286(39):34335-45. PubMed ID: 21795701 [TBL] [Abstract][Full Text] [Related]
12. Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. Casazza A; Kigel B; Maione F; Capparuccia L; Kessler O; Giraudo E; Mazzone M; Neufeld G; Tamagnone L EMBO Mol Med; 2012 Mar; 4(3):234-50. PubMed ID: 22247010 [TBL] [Abstract][Full Text] [Related]
13. Plexin D1 expression is induced on tumor vasculature and tumor cells: a novel target for diagnosis and therapy? Roodink I; Raats J; van der Zwaag B; Verrijp K; Kusters B; van Bokhoven H; Linkels M; de Waal RM; Leenders WP Cancer Res; 2005 Sep; 65(18):8317-23. PubMed ID: 16166308 [TBL] [Abstract][Full Text] [Related]
14. Semaphorin-plexin signalling genes associated with human breast tumourigenesis. Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246 [TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. Christensen C; Ambartsumian N; Gilestro G; Thomsen B; Comoglio P; Tamagnone L; Guldberg P; Lukanidin E Cancer Res; 2005 Jul; 65(14):6167-77. PubMed ID: 16024618 [TBL] [Abstract][Full Text] [Related]
17. Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers. Luchino J; Hocine M; Amoureux MC; Gibert B; Bernet A; Royet A; Treilleux I; Lécine P; Borg JP; Mehlen P; Chauvet S; Mann F Cancer Cell; 2013 Nov; 24(5):673-85. PubMed ID: 24139859 [TBL] [Abstract][Full Text] [Related]
18. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. Kigel B; Varshavsky A; Kessler O; Neufeld G PLoS One; 2008 Sep; 3(9):e3287. PubMed ID: 18818766 [TBL] [Abstract][Full Text] [Related]